Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 0.2948
+0.0080 (2.79%)
Aug 14, 2025, 4:59 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 439.43 million as of August 14, 2025. Its market cap has increased by 12.89% in one year.
Market Cap
439.43M
Enterprise Value
564.33M
Revenue
277.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 439.43M, an increase of 235.31%. That is a compound annual growth rate of 13.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.08B |
| Sectra AB | 67.17B |
| Getinge AB | 54.11B |
| Medicover AB | 40.69B |
| Asker Healthcare Group AB | 39.30B |
| Camurus AB | 38.15B |
| Bonesupport Holding AB | 20.44B |
| AddLife AB | 20.03B |